Advanced Biomedical Research on COVID-19 (2nd Edition)
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 21
Special Issue Editor
Interests: gynaecologic oncology; endometriosis; minimally invasive surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
SARS-Cov-2 has spread rapidly worldwide, with significant unexplainable differences in the rapidity of spread between countries. A real-time polymerase chain reaction (RT-PCR) obtained via nasopharyngeal swab was the most widely used method of detection for identifying the virus, but antibody testing also reveals specific IgG/IgM against SARSCoV-2. Although SARS‐CoV‐2 is highly contagious, neonates born to women with asymptomatic or symptomatic COVID‐19 are rarely infected with the virus.
This Special Issue aims to implement the current knowledge about novel diagnostic, prognostic, and therapeutic procedures for optimal management of COVID-19. Studies addressing maternal–fetal antibody status and obstetric outcomes of COVID-19 during pregnancy are of particular interest.
Dr. Federica Perelli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- COVID-19
- antibody
- infection
- immunity
Related Special Issue
- Advanced Biomedical Research on COVID-19 in Biomedicines (5 articles)
